Original language | English |
---|---|
Pages (from-to) | 643-666 |
Number of pages | 24 |
Journal | Human Gene Therapy |
Volume | 6 |
Issue number | 5 |
DOIs | |
State | Published - 1995 |
A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung
R. G. Crystal, A. Jaffe, S. Brody, A. Mastrangeli, N. G. McElvaney, M. Rosenfeld, C. S. Chu, C. Danel, J. Hay, T. Eissa
Research output: Contribution to journal › Review article › peer-review
62
Scopus
citations